Related Experiment Video
Updated: Oct 5, 2025

11:22
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
Published on: May 21, 2013
17.6K
Mesenchymal Stem Cell Exosomes Promote Functional Osteochondral Repair in a Clinically Relevant Porcine Model
Shipin Zhang1,2, Keng Lin Wong2,3, Xiafei Ren2,4
1Faculty of Dentistry, National University of Singapore, Singapore.
The American Journal of Sports Medicine
|January 31, 2022
Summary
Human mesenchymal stem cell (MSC) exosomes combined with hyaluronic acid (HA) safely promote osteochondral repair in a large animal model. This study supports clinical trials for treating osteochondral lesions.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Orthopedic Surgery
Background:
- Previous research indicated mesenchymal stem cell (MSC) exosome efficacy in small animal models for osteochondral defect repair.
- However, validation in a large, clinically relevant animal model was lacking.
Purpose of the Study:
- To assess the safety and efficacy of human MSC exosomes for osteochondral repair in a micropig model.
- To evaluate MSC exosomes in combination with hyaluronic acid (HA) for cartilage and subchondral bone regeneration.
Main Methods:
- Bilateral osteochondral defects were created in 12 micropigs.
- Groups received intra-articular injections of MSC exosomes + HA or HA alone at specific intervals.
- Assessment included MRI, macroscopic, histological, biomechanical, and micro-CT analyses.
Main Results:
- The Exosome+HA group showed significantly improved MRI scores at multiple time points.
- Enhanced cartilage and subchondral bone repair was observed in the Exosome+HA group, with superior macroscopic, histological, and biomechanical outcomes.
- Micro-CT revealed increased bone volume and trabecular thickness in the subchondral bone of the Exosome+HA group.
- No adverse events were reported in any animal.
Conclusions:
- Combined MSC exosomes and HA injections promote functional cartilage and subchondral bone repair in a porcine model.
- The treatment demonstrated improved morphological, histological, and biomechanical results.
- Findings support initiating Phase 1/2 clinical trials for osteochondral lesions.

